4-16009071-GAT-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_006017.3(PROM1):c.1177_1178del(p.Ile393ArgfsTer21) variant causes a frameshift change. The variant allele was found at a frequency of 0.000013 in 1,459,992 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.000013 ( 0 hom. )
Consequence
PROM1
NM_006017.3 frameshift
NM_006017.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.62
Genes affected
PROM1 (HGNC:9454): (prominin 1) This gene encodes a pentaspan transmembrane glycoprotein. The protein localizes to membrane protrusions and is often expressed on adult stem cells, where it is thought to function in maintaining stem cell properties by suppressing differentiation. Mutations in this gene have been shown to result in retinitis pigmentosa and Stargardt disease. Expression of this gene is also associated with several types of cancer. This gene is expressed from at least five alternative promoters that are expressed in a tissue-dependent manner. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 4-16009071-GAT-G is Pathogenic according to our data. Variant chr4-16009071-GAT-G is described in ClinVar as [Pathogenic]. Clinvar id is 208605.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-16009071-GAT-G is described in Lovd as [Likely_pathogenic]. Variant chr4-16009071-GAT-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROM1 | NM_006017.3 | c.1177_1178del | p.Ile393ArgfsTer21 | frameshift_variant | 12/28 | ENST00000447510.7 | NP_006008.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROM1 | ENST00000447510.7 | c.1177_1178del | p.Ile393ArgfsTer21 | frameshift_variant | 12/28 | 1 | NM_006017.3 | ENSP00000415481 | P3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248822Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134992
GnomAD3 exomes
AF:
AC:
3
AN:
248822
Hom.:
AF XY:
AC XY:
1
AN XY:
134992
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1459992Hom.: 0 AF XY: 0.0000165 AC XY: 12AN XY: 726342
GnomAD4 exome
AF:
AC:
19
AN:
1459992
Hom.:
AF XY:
AC XY:
12
AN XY:
726342
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 09, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 208605). This premature translational stop signal has been observed in individual(s) with autosomal recessive cone-rod dystrophy (PMID: 28041643). This variant is present in population databases (rs746174328, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Ile393Argfs*21) in the PROM1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PROM1 are known to be pathogenic (PMID: 17605048, 19718270, 24154662, 25474345). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 07, 2022 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Observed with a second PROM1 variant in an individual with cone rod dystrophy in published literature (Carss et al., 2017), although the phase of the two variants was not confirmed; This variant is associated with the following publications: (PMID: 31589614, 31129250, 32581362, 28041643) - |
Retinitis pigmentosa 41 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 20, 2015 | The p.Ile393ArgfsX21 variant in PROM1 has not been reported in the literature but has been identified in 2/65086 of European (Non-Finnish) chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 393 and leads to a premature termination codon 21 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Complete loss of PROM1 function is an established disease mechanism in retinitis pigmentosa. In summary, this variant meets our criteria to be classified as pathogenic for retinitis pigmentosa in an autosomal recessive manner (http://www.partners.org/personalizedmedicince/LMM) based upon the predicted impact to the protein. - |
Retinal dystrophy Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at